Merilas 810 shortpulse

- Laser therapy for advanced and end-stage glaucoma

merlias-sp819

Single spot 810nm laser photocoagulator designed for Retina and advanced end-stage Glaucoma treatment.

The 810nm wavelength is less absorbed by melanin and haemoglobin. This wavelength has the advantage of penetrating the sclera and excessive haemorrhage.

Merilase shortpulse 810 single pulse laser. Proven reliability – unified look.
Laser therapy for advanced and end-stage glaucoma.

logo_meridian
merilas-810-shortpulse-logo
Strong Points
Applications
Technologies
  • One laser: Two clinical applications (Glaucoma and Retina treatments.
  • The Merilas 810 shortpulse is cooled by a unique thermal electrical cooling system.
  • No ventilation slots are required. This ensures that no dust can penetrate into the interior of the laser.
  • Merilas 810 shortpulse can easily be transported to other practices or clinics.
  • The separate menu modes for easy identification of continuous wave and shortpulse mode ensure safe handling.
  • Colour-coded laser coupling to match the wavelength output.

RETINAL PHOTOCOAGULATION:

  • Diabetic Retinopathy.
  • Central Serous Chorioretinaopathy.
  • Diabetic Macular Edema.
  • Central/Branch Retinal Vein Occlusion.
  • Retinal Tears, Holes and Detachments.

GLAUCOMA:

  • Cyclophotocoagulation

Infrared 810nm

Hitech-Laser-Logo_350px

Hitech Lasers, as a member of The Hitech Group, has an established

proficiency as the leading Supplier of Laser Technologies in Southern Africa.

The family owned, South African registered company, celebrates:

Making a Difference since 1974.

We endeavour to make Life Easier for Doctors, Patients and all other

Users of Laser Technology.

The sustained Success of all Clients is our Satisfaction.

Customers become Partners.

2020 Hitech Lasers. Site by Studio Nexdoor